Nattokinase atherothrombotic prevention study: A randomized controlled trial.
Hodis HN, Mack WJ, Meiselman HJ, Kalra V, Liebman H, Hwang-Levine J, Dustin L, Kono N, Mert M, Wenby RB, Huesca E, Rochanda L, Li Y, Yan M, St John JA, Whitfield L.
Hodis HN, et al.
Clin Hemorheol Microcirc. 2021;78(4):339-353. doi: 10.3233/CH-211147.
Clin Hemorheol Microcirc. 2021.
PMID: 33843667
Clinical Trial.
BACKGROUND: Described to be antithrombotic and antihypertensive, nattokinase is consumed for putative cardiovascular benefit. However, no large-scale, long-term cardiovascular study has been conducted with nattokinase supplementation. ...RESULTS: After median 3 year …
BACKGROUND: Described to be antithrombotic and antihypertensive, nattokinase is consumed for putative cardiovascular benefit. However …